Use a Wearable Devices to Observe Complications of Mobilization for Colorectal Cancer After Surgery

This study aims to help patients recover faster after colorectal cancer surgery by using wearable devices to monitor early movement.

Patients will wear a lightweight wristband that tracks heart rate, sleep, and daily steps after surgery. The goal is to find out if early walking can reduce the chances of complications, shorten hospital stays, and lower medical costs.

Participants will start wearing the device after surgery and continue for about 7 days or until they leave the hospital. During this time, they will also fill out a simple daily observation form. Participation is voluntary, and patients can withdraw at any time without affecting their care.

The study hopes to provide new ways to improve recovery and offer better support to patients after colorectal surgery.

Study Overview

• Status: Completed
• Conditions: Colorectal Cancer

• Study Type: Observational
• Enrollment (Actual): 192

Contacts and Locations

Study Locations

• Taiwan
  • Taoyuan District, Taiwan, 333
    • Chang Gung Memorial Hospital, Linkou

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Adults aged 20 to 85 years diagnosed with colorectal cancer who underwent minimally invasive surgery at a medical center. Patients must be able to communicate in Mandarin or Taiwanese and provide informed consent.

Description

Inclusion Criteria:

1. Patients undergoing minimally invasive colorectal tumor resection.
2. Aged 20 to 85 years.
3. ECOG score 0-2.
4. Clear consciousness and ability to communicate in Mandarin or Taiwanese (or via family translation).
5. Informed consent provided by the patient or family.

Exclusion Criteria:

1. Patients with acute/chronic psychiatric disorders or cognitive impairment.
2. Patients undergoing traditional open or local resection surgeries.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Postoperative Colorectal Cancer Patients with Wearable Device Monitoring; Patients diagnosed with colorectal cancer who underwent minimally invasive surgery. Participants wore a wrist-worn device to monitor postoperative physical activity, heart rate, and sleep for up to 7 days or until discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Hospital Length of Stay	The number of calendar days from the date of colorectal surgery to the date of hospital discharge, recorded from the hospital electronic medical record.	Through hospital discharge (an average of 7 days after surgery)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Postoperative Complications (Clavien-Dindo classification)	The occurrence and severity of postoperative complications during hospitalization, graded using the Clavien-Dindo classification system based on medical record review.	Postoperative Day 30

Collaborators and Investigators

• Sponsor: Chang Gung Memorial Hospital

Study record dates

Study Major Dates

• Study Start (Actual): August 8, 2022
• Primary Completion (Actual): January 5, 2024
• Study Completion (Actual): January 8, 2024

Study Registration Dates

• First Submitted: August 20, 2025
• First Submitted That Met QC Criteria: December 15, 2025
• First Posted (Actual): December 17, 2025

Study Record Updates

• Last Update Posted (Actual): December 17, 2025
• Last Update Submitted That Met QC Criteria: December 15, 2025
• Last Verified: August 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms by Site; Neoplasms; Intestinal Diseases; Gastrointestinal Neoplasms; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Colonic Diseases; Colorectal Neoplasms
• Other Study ID Numbers: 202102412B0; CMRPG3M2171 (Other Grant/Funding Number: Chang Gung Memorial Hospital, Linkou)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Individual Participant Data (IPD) will not be shared due to the need to protect patient privacy and confidentiality. Additionally, there are no current plans for secondary analysis or collaboration with external researchers.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No